<h1 id="pneumonia-risk-stratification-scoring-tools">Pneumonia: Risk Stratification Scoring Tools</h1>
<h2 id="pneumonia-severity-index-psi-">Pneumonia Severity Index (PSI)</h2>
<ul>
<li>From Pneumonia Patient Outcomes Research Team (PORT) </li>
<li>A large derivation and validation study with &gt; 50,000 patients</li>
<li>Best identifies low-risk/ low-mortality patients</li>
<li>Tends to miss higher-risk pneumonia in younger patients because score is based on age </li>
<li>Does not factor in immunosuppression (eg. HIV) and poor social support. </li>
</ul>
<table>
<thead>
<tr>
<th><strong>Risk factors</strong></th>
<th><strong>Points</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>Men</td>
<td>Age (years)</td>
</tr>
<tr>
<td>Women</td>
<td>Age (years)-10</td>
</tr>
<tr>
<td>Nursing home resident</td>
<td>+10</td>
</tr>
<tr>
<td>History of neoplasm</td>
<td>+30</td>
</tr>
<tr>
<td>History of liver disease</td>
<td>+20</td>
</tr>
<tr>
<td>History of heart failure</td>
<td>+10</td>
</tr>
<tr>
<td>History of stroke</td>
<td>+10</td>
</tr>
<tr>
<td>History of renal failure</td>
<td>+10</td>
</tr>
<tr>
<td>Altered mental status</td>
<td>+20</td>
</tr>
<tr>
<td>RR ≥ 30 breaths/ min</td>
<td>+20</td>
</tr>
<tr>
<td>SBP &lt; 90 mmHg</td>
<td>+20</td>
</tr>
<tr>
<td>Temp &lt; 95F (35C) or ≥104F (40C)</td>
<td>+15</td>
</tr>
<tr>
<td>HR ≥ 125 bpm</td>
<td>+10</td>
</tr>
<tr>
<td>Arterial pH &lt; 7.35</td>
<td>+30</td>
</tr>
<tr>
<td>BUN &gt; 30 mg/dL</td>
<td>+20</td>
</tr>
<tr>
<td>Na &lt; 130 mmol/L</td>
<td>+20</td>
</tr>
<tr>
<td>Glucose ≥250 mg/dL</td>
<td>+10</td>
</tr>
<tr>
<td>Hematocrit &lt; 30%</td>
<td>+10</td>
</tr>
<tr>
<td>PaO2 &lt; 60 mmHg</td>
<td>+10</td>
</tr>
<tr>
<td>Pleural effusion</td>
<td>+10</td>
</tr>
</tbody>
</table>
<table>
<thead>
<tr>
<th><strong>PSI Class</strong></th>
<th><strong>Total points</strong></th>
<th><strong>30-day mortality</strong></th>
<th><strong>Disposition</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>I</td>
<td>&lt; 51</td>
<td>0.1%</td>
<td>Outpatient</td>
</tr>
<tr>
<td>II</td>
<td>51-70</td>
<td>0.6%</td>
<td>Outpatient</td>
</tr>
<tr>
<td>III</td>
<td>71-90</td>
<td>0.9%</td>
<td>Outpatient vs short-stay inpatient</td>
</tr>
<tr>
<td>IV</td>
<td>91-130</td>
<td>9.3%</td>
<td>Inpatient</td>
</tr>
<tr>
<td>V</td>
<td>&gt; 130</td>
<td>27.0%</td>
<td>Inpatient ICU</td>
</tr>
</tbody>
</table>
<p>(<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086">Fine et al., JAMA 1997)</a></p>
<h2 id="curb-65-severity-score">CURB-65 Severity Score</h2>
<p>* Supported by British Thoracic Society (BTS)</p>
<ul>
<li>Best identifies high-risk/ high-mortality patients</li>
<li>Tends to misclassify moderate-risk pneumonia patients (as low-risk) </li>
<li>Does not account for co-morbidities and hypoxemia</li>
</ul>
<table>
<thead>
<tr>
<th></th>
<th><strong>Risk factor</strong></th>
<th><strong>Points</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>C</strong></td>
<td><strong>C</strong>onfusion</td>
<td>1</td>
</tr>
<tr>
<td><strong>U</strong></td>
<td>Uremia (BUN &gt;19 mg/dL)</td>
<td>1</td>
</tr>
<tr>
<td><strong>R</strong></td>
<td><strong>R</strong>R ≥ 30 breaths/min</td>
<td>1</td>
</tr>
<tr>
<td><strong>B</strong></td>
<td><strong>B</strong>P low (SBP &lt; 90 mmHg or DBP &lt; 60 mmHg)</td>
<td>1</td>
</tr>
<tr>
<td><strong>65</strong></td>
<td>Age ≥ <strong>65</strong> years</td>
<td>1</td>
</tr>
</tbody>
</table>
<table>
<thead>
<tr>
<th><strong>Total points</strong></th>
<th><strong>30-day mortality</strong></th>
<th><strong>Disposition</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>0</td>
<td>0.6%</td>
<td>Outpatient</td>
</tr>
<tr>
<td>1</td>
<td>3.2%</td>
<td>Outpatient</td>
</tr>
<tr>
<td>2</td>
<td>13.0%</td>
<td>Outpatient or short-stay inpatient</td>
</tr>
<tr>
<td>3</td>
<td>17%</td>
<td>Inpatient</td>
</tr>
<tr>
<td>4</td>
<td>41.5%</td>
<td>Inpatient, likely ICU</td>
</tr>
<tr>
<td>5</td>
<td>57.0%</td>
<td>Inpatient ICU</td>
</tr>
</tbody>
</table>
<p>(<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364">British Thoracic Society Standards of Care Committee</a> &amp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136"> </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136">Aujesky et al, Am J Med, 2005</a>) </p>
<h2 id="smart-cop">SMART-COP</h2>
<p>Supported by Australian CAP Study</p>
<ul>
<li>Tool to predict need for intensive respiratory or vasopressor support (IRVS) </li>
</ul>
<table>
<colgroup>
<col width="33%" />
<col width="33%" />
<col width="33%" />
</colgroup>
<thead>
<tr class="header">
<th><br />
</th>
<th><strong>Risk factor</strong></th>
<th><strong>Points</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>S</strong></td>
<td><strong>S</strong>ystolic BP &lt; 90 mmHg</td>
<td>2</td>
</tr>
<tr class="even">
<td><strong>M</strong></td>
<td><strong>M</strong>ultilobar CXR involvement</td>
<td>1</td>
</tr>
<tr class="odd">
<td><strong>A</strong></td>
<td><strong>A</strong>lbumin &lt; 3.5 g/dL</td>
<td>1</td>
</tr>
<tr class="even">
<td><strong>R</strong></td>
<td>If age ≤ 50 years: <strong>R</strong>R ≥ 25 breaths/min <br />
If age &gt; 50 years: <strong>R</strong>R ≥ 30 breaths min <br />
</td>
<td>1</td>
</tr>
<tr class="odd">
<td><strong>T</strong></td>
<td><strong>T</strong>achycardia HR ≥ 125 bpm </td>
<td>1</td>
</tr>
<tr class="even">
<td><strong>C</strong></td>
<td><strong>C</strong>onfusion (new onset)</td>
<td>1<br />
</td>
</tr>
<tr class="odd">
<td><strong>O</strong></td>
<td><strong>O</strong>xygen low<br />

<p>If age ≤50 years: </p>
<ul>
<li>PaO2 &lt; 70 mmHg, or<br />
</li>
<li>O2 sat ≤ 93%, or<br />
</li>
<li>PaO2/FiO2 &lt; 333<br />
</li>
</ul>
<p>If age &gt;50 years:</p>
<ul>
<li>PaO2 &lt; 60 mmHg, or</li>
<li>O2 sat ≤ 90%, or </li>
<li>PaO2/FiO2 &lt; 250 </li>
</ul></td>
<td>2</td>
</tr>
<tr class="even">
<td><strong>P</strong></td>
<td>Arterial <strong>p</strong>H &lt; 7.35</td>
<td>2</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr>
<th><strong>Total points</strong></th>
<th><strong>Risk of needing IRVS</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>0-2</td>
<td>Low</td>
</tr>
<tr>
<td>3-4</td>
<td>Moderate ( 1 in 8)</td>
</tr>
<tr>
<td>5-6</td>
<td>High (1 in 3)</td>
</tr>
<tr>
<td>≥ &amp;</td>
<td>Very high (2 in 3)</td>
</tr>
</tbody>
</table>
<p>(<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884">Charles et al., Clin Infect Dis, 2008</a>)</p>
<h2 id="references">References</h2>
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136">Aujesky D et. al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005 Apr;118(4):384-92.</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086">Fine MJ et. al. A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med. 1997 Jan 23;336(4):243-50.</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884">Charles PG et. al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008 Aug 1;47(3):375-84.</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364">British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax. 2001 Dec;56 Suppl 4:IV1-64.</a></li>
</ul>
